Sergliflozin A

CAS No. 360775-96-8

Sergliflozin A( —— )

Catalog No. M36251 CAS No. 360775-96-8

Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 247 In Stock
10MG 371 In Stock
25MG 620 In Stock
50MG 863 In Stock
100MG 1172 In Stock
200MG Get Quote In Stock
500MG 2353 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sergliflozin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
  • Description
    Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    SGLT
  • Recptor
    SGLT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    360775-96-8
  • Formula Weight
    376.4
  • Molecular Formula
    C20H24O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C1=C(CC2=CC=C(OC)C=C2)C=CC=C1)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bexagliflozin

    A potent and selective SGLT2 inhibitor with IC50 of 2 nM; shows little activity for SGLT1 (IC50=5.6 uM).

  • Canagliflozin

    A highly potent and selective SGLT2 inhibitor with IC50 of 4.4, 3.7 and 2.0 nM for hSGLT2, rSGLT2 and mSGLT2, respectively.

  • Mizagliflozin

    Mizagliflozin (DSP-3235, KGA-3235, GSK-1614235)?is a potent, selective, orally active SGLT1 inhibitor with Ki of 27 nM, displays >350-fold selectivity over SGLT2.